The Survival Relationship between Preoperative Inflammation Markers and Patients with Special Pathological Types of Gastric Cancer

BACKGROUND: The preoperative PLR is closely associated with prognosis of gastric cancer. This aims to research whether the PLR could predict overall survival (OS) of gastric cancer (GC) patients with SRC component. METHODS: The data were collected from Harbin Medical University Cancer Hospital between January 2001 and December 2013 in China. The patients were diagnosed with GC by pathologic examination, which contained SRC component in pathological organization. PLR is obtained from peripheral blood markers (platelets/lymphocytes). RESULTS: There is a difference in OS between high PLR group and low group, which is verified by Kaplan–Meier analysis and log-rank tests (P < 0.001). Moreover, multivariate analysis prove PLR was independent prognostic factor for GC (HR = 1.384, 95% (CI): 1.048–1.828; P = 0.022). The preoperative PLR in stage I + II (P = 0.033), stage III (P < 0.001), SRC component lower than 50% (P < 0.001), SRC component equal to or higher than 50% (P = 0.044), and R0 resection (P < 0.001) GC are still effective. CONCLUSION: PLR is a simple, useful, and repeatable predictor of OS in gastric cancer of stages I–III with SRC component and may help clinicians identify patients with high risk and develop a more reasonable follow-up plan.